The UC Davis M.I.N.D. Institute entered into an agreement with a company to analyze clinical samples from children to identify unique properties in the blood chemistry of those with autism. The study is intended to be a step in the development of a diagnostic test for the neurodevelopmental disorder.
An earlier, groundbreaking study found elevated peptides in children with either autism or mental retardation. The M.I.N.D. Institute entered into an agreement with SurroMed, Inc., based in Mountain View, Calif. to analyze biological samples from 105 children – about 70 with autism and the remainder with normal development.